Ceftriaxone is a third-generation cephalosporin commonly used to treat infection. However, encephalopathy is an emerging adverse effect of ceftriaxone infusion. These patients present with various symptoms, including those of neurotoxicity, that typically resolve 1 week after discontinuation of ceftriaxone. We experienced two cases of ceftriaxone-induced encephalopathy that were successfully treated by rapid removal of ceftriaxone by hemoperfusion.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545014PMC
http://dx.doi.org/10.1111/hdi.13018DOI Listing

Publication Analysis

Top Keywords

cases ceftriaxone-induced
8
ceftriaxone-induced encephalopathy
8
encephalopathy treated
8
treated hemoperfusion
4
hemoperfusion hemodialysis
4
hemodialysis patients
4
ceftriaxone
4
patients ceftriaxone
4
ceftriaxone third-generation
4
third-generation cephalosporin
4

Similar Publications

Unraveling the complexity: Case reports of drug-induced hemolytic anemia due to ceftriaxone.

Asian J Transfus Sci

August 2024

Department of Immunohematology and Transfusion Medicine, Santokba Durlabhji Memorial Hospital, Jaipur, Rajasthan, India.

Drug-induced hemolytic anemia (DIHA) is a rare but significant condition characterized by the premature destruction of red blood cells (RBCs) triggered by certain medications. Ceftriaxone, a commonly used antibiotic, has been linked to DIHA, presenting diagnostic challenges due to its diverse clinical manifestations. This study examines three cases of DIHA caused by ceftriaxone therapy at our center.

View Article and Find Full Text PDF

The spleen plays a crucial role in filtering aging blood cells and defending against encapsulated microorganisms. While not essential for survival, splenic dysfunction can lead to severe complications, including organ failure, infection, and death. This case study examines a rare presentation of drug-induced splenic septic thrombophlebitis secondary to pancreatitis caused by an adverse reaction to ceftriaxone.

View Article and Find Full Text PDF
Article Synopsis
  • A patient with miliary tuberculosis was diagnosed with drug-induced immune thrombocytopenia (DITP) caused by ceftriaxone, contrary to the initial assumption that it was due to the tuberculosis drugs.
  • Identifying the specific drug causing DITP is crucial to ensure continuation of essential tuberculosis treatment without unnecessary changes.
  • When multiple medications are involved, additional testing for drug-dependent platelet antibodies may be needed to make an informed decision about treatment adjustments.
View Article and Find Full Text PDF

Ceftriaxone is a third-generation cephalosporin. Due to its wide range of activity and acceptable safety profile, it is frequently prescribed to paediatric patients. However, there are several documented cases of reports of uncommon adverse events, such as cholecystitis, linked to the use of ceftriaxone.

View Article and Find Full Text PDF

Clinical and biochemical characteristics, and outcome in 33 patients with ceftriaxone-induced liver injury.

Eur J Clin Pharmacol

September 2024

Department of Pediatrics, The First Affiliated Hospital of Guangxi Medical University, Difficult and Critical illness Center, Pediatric Clinical Medical Research Center of Guangxi, Nanning, Guangxi Zhuang Autonomous Region, China.

Purpose: To summarize the clinical and biochemical characteristics of patients with ceftriaxone-induced liver injury and guide the selection of safe medication.

Methods: Retrieved domestic and foreign databases from inception to October 2023, collected case data conforming to ceftriaxone-induced liver injury, and statistically analyzed the data.

Results: A total of 617 articles were retrieved, and 16 articles with 33 cases (10 children, 23 adults) were included.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!